Colombia to Force Novartis to Lower Prices of Cancer Drug - (ABC News via NewsPoints Desk)

  • Colombia's government is unilaterally forcing Novartis to lower prices of leukaemia drug Gleevec, ABC News reported Thursday.
  • Health Minister Alejandro Gaviria said two weeks of negotiations with the drugmaker ended without an agreement on lowering prices.
  • Gaviria noted that he is now drafting a resolution that will shortly declare Gleevec in the public's interest.

To read more NewsPoints articles, click here.